Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aytu Biopharma, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.157 Good day, everyone, and welcome to the A2 Biopharma Fiscal 2026 Second Quarter 00:00:05.157 -- 00:00:07.139 Earnings Call. 00:00:07.139 -- 00:00:11.544 At this time, all participants are placed on a listen-only mode, and we will open the 00:00:11.544 -- 00:00:14.147 floor for your questions and comments after the presentation. 00:00:14.147 -- 00:00:19.253 It is now my pleasure to hand the floor over to your host, Robert Bloom. 00:00:19.253 -- 00:00:21.296 Sir, the floor is yours. 00:00:21.296 -- 00:00:23.738 All right. Thank you very much, and good afternoon, everyone. 00:00:23.738 -- 00:00:27.301 As the operator indicated during today's call, we will be discussing... 00:00:27.301 -- 00:00:32.567 A2 Biopharma's fiscal 2026 second quarter operational and financial 00:00:32.567 -- 00:00:37.090 results for the period ended December 31, 2025. 00:00:37.813 -- 00:00:42.979 Joining us on today's call is A2's chief executive officer, Josh Disbrow, and Ryan 00:00:42.979 -- 00:00:46.444 Selhorn, the company's chief financial officer. 00:00:46.444 -- 00:00:50.168 At the conclusion of today's prepared remarks, we'll open the call for a question and 00:00:50.168 -- 00:00:54.841 answer session. I'd like to remind everyone that today's call is being recorded. 00:00:54.841 -- 00:01:00.107 A replay of today's call will be available by using the telephone numbers and conference 00:01:00.107 -- 00:01:05.193 ID provided in the press release issued earlier today or by utilizing the link 00:01:05.193 -- 00:01:09.497 on the company's website under events and presentations. 00:01:09.497 -- 00:01:14.103 Finally, I'd also like to call your attention the customary safe harbor disclosure regarding 00:01:14.103 -- 00:01:19.088 forward-looking information. The ...